Page 53 - Comprehensive treatment of patients with glucocorticoid-dependent severe asthma

143. Evans DJ, Cullinan P, Geddes DM. Cyclosporin as an oral corticosteroid sparing agent in stable asthma. Cochrane Database Syst Rev 2001;(2):CD002993.
144. Nelson HS, Hamilos DL, Corsello PR, et al. A double-blind study of troleandomycin and methylprednisolone in asthmatic subjects who require daily corticosteroids. Am Rev Respir Dis 1993;147:398-404.
145. Bernstein IL, Bernstein DI, Dubb JW, et al. A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma. Auranofin Multicenter Drug Trial. J Allergy Clin Immunol 1996;98:317-24.
146. Frew AJ, Plummeridge MJ. Alternative agents in asthma. J Allergy Clin Immunol 2001; 108:3-10.
147. Niven AS, Argyros G. Alternate treatments in asthma. Chest 2003;123:1254-65.
148. Flood-Page P, Menzies-Gow A, Phipps S, et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003;112:1029-36.
149. Leckie MJ, Ten Brinke A, Khan J, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356:2144- 8.
150. Nair P, Pizzichini MM, Kjarsgaard M, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009;360:985-93.
151. Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009;360:973-84.
152. Camargo CA Jr., Weiss ST, Zhang S, et al. Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med 1999; 159:2582-8.
153. Dixon AE, Holguin F, Sood A, et al. An official American Thoracic Society Workshop report: obesity and asthma. Proc Am Thorac Soc 2010;7:325-35.
154. Von Behren J, Lipsett M, Horn-Ross PL, et al. Obesity, waist size and prevalence of current asthma in the California Teachers Study cohort. Thorax 2009; 64:889-93.
155. Mosen DM, Schatz M, Magid DJ, Camargo CA Jr. The relationship between obesity and asthma severity and control in adults. J Allergy Clin Immunol 2008;122:507-11.
156. Taylor B, Mannino D, Brown C, Crocker D, et al. Body mass index and asthma severity in the National Asthma Survey. Thorax 2008;63:14-20.
157. Peters JI, McKinney JM, Smith B, et al. Impact of obesity in asthma: evidence from a large prospective disease management study. Ann Allergy Asthma Immunol 2011;106:30-5.
158. Romagnoli I, Laveneziana P, Clini EM, et al. Role of hyperinflation vs. deflation on dyspnoea in severely to extremely obese subjects. Acta Physiol (Oxf ) 2008; 193:393-402.
159. Shore SA. Obesity, airway hyperresponsiveness, and inflammation. J Appl Physiol 2010;108:735-43.
160. Sabate JM, Jouet P, Merrouche M, et al. Gastroesophageal reflux in patients with morbid obesity: a role of obstructive sleep apnea syndrome?. Obes Surg 2008;18:1479-84.
161. Stenius-Aarniala B, Poussa T, Kvarnstrom J, et al. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ 2000; 320:827-32.
162. Macgregor AM, Rand CS. Gastric surgery in morbid obesity. Outcome in patients aged 55 years and older. Arch Surg 1993; 128:1153-7.
163. Reddy RC, Baptist AP, Fan Z, et al. The effects of bariatric surgery on asthma severity. Obes Surg 2011;21:200-6.
164. Julien JY, Martin JG, Ernst P, et al. Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma. J Allergy Clin Immunol 2009;124:371-6.
165. Alkhalil M, Schulman ES, Getsy J. Obstructive sleep apnea syndrome and asthma: the role of continuous positive airway pressure treatment. Ann Allergy Asthma Immunol 2008; 101:350-7.
166. Chan CS, Woolcock AJ, Sullivan CE. Nocturnal asthma: role of snoring and obstructive sleep apnea. Am Rev Respir Dis 1988;137:1502-4.
167. Lafond C, Series F, Lemiere C. Impact of CPAP on asthmatic patients with obstructive sleep apnoea. Eur Respir J 2007;29:307-11.
168. Nilsson M, Johnsen R, Ye W, et al. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 2003;290:66-72.
Current treatment of severe asthma
51
2